| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0039 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0092 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |